BNIP3L and obesity disorder: In parallel, exploring the therapeutic potential of modulating mitophagy pathways, for example, by using pharmacological agents to activate or inhibit BNIP3L, may help determine whether targeting mitophagy can effectively reduce adipose tissue inflammation and improve metabolic outcomes in obesity.